» Articles » PMID: 21460211

High Mannose-binding Lectin with Preference for the Cluster of Alpha1-2-mannose from the Green Alga Boodlea Coacta is a Potent Entry Inhibitor of HIV-1 and Influenza Viruses

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Apr 5
PMID 21460211
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The complete amino acid sequence of a lectin from the green alga Boodlea coacta (BCA), which was determined by a combination of Edman degradation of its peptide fragments and cDNA cloning, revealed the following: 1) B. coacta used a noncanonical genetic code (where TAA and TAG codons encode glutamine rather than a translation termination), and 2) BCA consisted of three internal tandem-repeated domains, each of which contains the sequence motif similar to the carbohydrate-binding site of Galanthus nivalis agglutinin-related lectins. Carbohydrate binding specificity of BCA was examined by a centrifugal ultrafiltration-HPLC assay using 42 pyridylaminated oligosaccharides. BCA bound to high mannose-type N-glycans but not to the complex-type, hybrid-type core structure of N-glycans or oligosaccharides from glycolipids. This lectin had exclusive specificity for α1-2-linked mannose at the nonreducing terminus. The binding activity was enhanced as the number of terminal α1-2-linked mannose substitutions increased. Mannobiose, mannotriose, and mannopentaose were incapable of binding to BCA. Thus, BCA preferentially recognized the nonreducing terminal α1-2-mannose cluster as a primary target. As predicted from carbohydrate-binding propensity, this lectin inhibited the HIV-1 entry into the host cells at a half-maximal effective concentration of 8.2 nm. A high association constant (3.71 × 10(8) M(-1)) of BCA with the HIV envelope glycoprotein gp120 was demonstrated by surface plasmon resonance analysis. Moreover, BCA showed the potent anti-influenza activity by directly binding to viral envelope hemagglutinin against various strains, including a clinical isolate of pandemic H1N1-2009 virus, revealing its potential as an antiviral reagent.

Citing Articles

Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions.

Owliaee I, Khaledian M, Shojaeian A, Madanchi H, Yarani R, Boroujeni A Probiotics Antimicrob Proteins. 2025; .

PMID: 39776036 DOI: 10.1007/s12602-024-10430-0.


A Complex-Type -Glycan-Specific Lectin Isolated from Green Alga Anti-Influenza Virus Activity.

Mu J, Hirayama M, Morimoto K, Hori K Int J Mol Sci. 2024; 25(8).

PMID: 38673930 PMC: 11050134. DOI: 10.3390/ijms25084345.


Mannose-specific plant and microbial lectins as antiviral agents: A review.

Gupta A, Yadav K, Yadav A, Ahmad R, Srivastava A, Kumar D Glycoconj J. 2024; 41(1):1-33.

PMID: 38244136 DOI: 10.1007/s10719-023-10142-7.


The Antiviral Potential of Algal Lectins.

Alvarez C, Felix C, Lemos M Mar Drugs. 2023; 21(10).

PMID: 37888450 PMC: 10608189. DOI: 10.3390/md21100515.


Antiviral Peptides as Anti-Influenza Agents.

Agamennone M, Fantacuzzi M, Vivenzio G, Scala M, Campiglia P, Superti F Int J Mol Sci. 2022; 23(19).

PMID: 36232735 PMC: 9569631. DOI: 10.3390/ijms231911433.


References
1.
Boyd M, Gustafson K, McMahon J, Shoemaker R, OKeefe B, Mori T . Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother. 1997; 41(7):1521-30. PMC: 163952. DOI: 10.1128/AAC.41.7.1521. View

2.
Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C . Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology. 2004; 14(12):1229-46. DOI: 10.1093/glycob/cwh106. View

3.
Fouquaert E, Hanton S, Brandizzi F, Peumans W, Van Damme E . Localization and topogenesis studies of cytoplasmic and vacuolar homologs of the Galanthus nivalis agglutinin. Plant Cell Physiol. 2007; 48(7):1010-21. DOI: 10.1093/pcp/pcm071. View

4.
Bewley C, Gustafson K, Boyd M, Covell D, Bax A, Clore G . Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat Struct Biol. 1998; 5(7):571-8. DOI: 10.1038/828. View

5.
Lee Y, Townsend R, Hardy M, Lonngren J, Arnarp J, Haraldsson M . Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J Biol Chem. 1983; 258(1):199-202. View